Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amphastar Receives FDA Approval For Regadenoson Following Solid Q1
Multiple Pipeline Launches Expected For H2
May 30 2022
•
By
Chloe Kent
Amphastar expects to launch at least two new generics this year • Source: Shutterstock
More from Earnings
More from Business